http://www.foxbusiness.com/news/2013/05/23/royalty-pharma-lowers-acceptance-threshold-for-elan-offer/ http://www.foxbusiness.com/news/2013/05/23/dissident-holder-first-manhattan-adds-3-to-vivus-board-slate/ http://www.foxbusiness.com/news/2013/05/20/royalty-pharma-raises-takeover-bid-for-elan/ http://www.foxbusiness.com/news/2013/05/20/elan-sets-out-deal-plans/ http://www.foxbusiness.com/news/2013/05/13/elan-1-billion-drug-royalty-deal-aids-bid-defense/ http://www.foxbusiness.com/news/2013/05/13/elan-signs-1-billion-drug-deal/ http://www.foxbusiness.com/news/2013/05/10/sp-highlights-biotech-etfs/ http://www.foxbusiness.com/news/2013/05/02/teva-pharmaceutical-profit-falls-on-lower-generic-sales/ http://www.foxbusiness.com/news/2013/04/30/equal-weight-etf-trounces-traditional-sp-500-peers/ http://www.foxbusiness.com/news/2013/04/26/as-biotechnology-stocks-soar-bubble-talk-percolates/ http://www.foxbusiness.com/news/2013/04/25/biogen-profits-jump-41-stays-mum-on-key-drug-launch/ http://global.fncstatic.com/static/managed/img/fb2/video/042513_Imus_Biogen.jpg http://www.foxbusiness.com/news/2013/04/25/biogen-1st-quarter-net-rose-41-on-higher-multiple-sclerosis-drugs-sales/ http://www.foxbusiness.com/news/2013/04/24/ingredient-in-biogen-tecfidera-ms-drug-linked-to-brain-infection/ http://www.foxbusiness.com/news/2013/04/23/market-wrap-for-april-22-stocks-rise-moderately-to-begin-week/ http://www.foxbusiness.com/news/2013/04/22/biotech-mutual-funds-show-etfs-are-place-to-be/ http://www.foxbusiness.com/news/2013/04/22/elan-board-rejects-royalty-pharma-takeover-bid/ http://www.foxbusiness.com/news/2013/04/21/look-ahead-this-week-etfs-to-watch/ http://www.foxbusiness.com/news/2013/04/18/baxter-sales-rise-but-health-care-pressures-remain/ http://www.foxbusiness.com/news/2013/04/18/elan-1-billion-tender-oversubscribed/ http://www.foxbusiness.com/news/2013/04/18/elan-accepts-tenders-for-88-million-shares-at-1125-share/